Join our daily newsletter At The Bell to receive exclusive market insights
- EZZ Life Sciences (EZZ) determines a fully franked final dividend for FY22 of 0.45 cents
- It comes after the company sharpened its focus on cost control over the financial year, boosting its operating cashflows
- Over the 12-month period, the company improved its overall financial position, lifting cash and cash equivalents by 18 per cent to $10.46 million
- The dividends will be paid on December 16, with the ex-dividend date to land on November 3 and the record date on November 4
- Shares are trading steady in early trade at 30.5 cents each at 11:20 am AEDT
EZZ Life Sciences (EZZ) has determined a fully franked final dividend for FY22 of 0.45 cents.
It comes after the genomic life science company sharpened its focus on cost control over the financial year, with marketing costs reducing by $4.88 million and cost of sales declining by over $2 million.
This resulted in a boost to its operating cashflows to $1.9 million.
EZZ reported earnings before interest, tax, depreciation and amortisation (EBITDA) of $1.7 million.
Over the 12-month period, the company improved its overall financial position, lifting cash and cash equivalents by 18 per cent to $10.46 million.
The dividends will be paid on December 16, with the ex-dividend date to land on November 3 and the record date on November 4.
Shares were trading steady in early trade at 30.5 cents each at 11:20 am AEDT.
